Dravet Syndrome Treatment Market size is poised to reach USD 1 Billion by the end of 2036, growing at a CAGR of 11% during the forecast period, i.e., 2024 – 2036. In the year 2023, the industry size of dravet syndrome treatment was USD 0.37 Billion. The reason behind the growth is impelled by the increasing child population. Moreover, Dravet syndrome is an uncommon kind of epilepsy that starts in infancy or early childhood and can lead to frequent, protracted seizures, which may require treatment including medication or other therapies to decrease the severity and amount of seizures.According to estimates, the number of children worldwide is projected to be over 1 billion in 2100.
The growing research & development are believed to fuel the dravet syndrome treatment market. For instance, in 2020 STK-001 an anti-sense oligonucleotide was administered, to the first patient with Dravet syndrome as part of a clinical trial to increase the expression of SCN1A in the brain.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?